127 related articles for article (PubMed ID: 10494726)
1. Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma.
Herrera Saval A; Camacho Martínez F
Acta Derm Venereol; 1999 Sep; 79(5):395. PubMed ID: 10494726
[No Abstract] [Full Text] [Related]
2. Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma.
Nishihori T; Abdo-Matkiwsky M; Fleishman SB; Blum RH
Am J Clin Oncol; 2005 Oct; 28(5):526. PubMed ID: 16199995
[TBL] [Abstract][Full Text] [Related]
3. Grand mal seizure induced by interferon-alpha-2b.
Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
[No Abstract] [Full Text] [Related]
4. Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury A; El Sayed F; Farah C; Bazex J
J Am Acad Dermatol; 2008 Mar; 58(3):532-3. PubMed ID: 18280369
[No Abstract] [Full Text] [Related]
5. Delayed wound healing following treatment with low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury AF; El Sayed F; Bazex J
Arch Dermatol; 2007 Oct; 143(10):1339-40. PubMed ID: 17938359
[No Abstract] [Full Text] [Related]
6. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
Alonso-Pérez A; Ballestero-Díez M; Fraga J; García-Díez A; Fernández-Herrera J
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1328-9. PubMed ID: 17062055
[No Abstract] [Full Text] [Related]
7. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma?
Radny P; Bauer J; Caroli UM; Eigentler TK; Kamin A; Metzler G; Garbe C
Dermatology; 2004; 209(3):249-50. PubMed ID: 15459547
[No Abstract] [Full Text] [Related]
9. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Siegelmann-Danieli N; Bardo M; Law A; Fisk D; Bernath A
Isr Med Assoc J; 2004 Oct; 6(10):636-7. PubMed ID: 15473596
[No Abstract] [Full Text] [Related]
10. Hypertriglyceridaemia following adjuvant interferon-alpha treatment in two patients with malignant melanoma.
Junghans V; Rünger TM
Br J Dermatol; 1999 Jan; 140(1):183-4. PubMed ID: 10215802
[No Abstract] [Full Text] [Related]
11. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
Kiley KE; Gale DM
Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous necrosis due to interferon alpha in a patient with melanoma].
Aguilar García G; Serrano Falcón C; Serrano Falcón Mdel M; Carmona MD; Linares Solano J; Serrano Ortega S
Actas Dermosifiliogr; 2006 Oct; 97(8):539-42. PubMed ID: 17067536
[TBL] [Abstract][Full Text] [Related]
13. Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon alpha-2b.
Helbig D; Simon JC; Treudler R
Acta Derm Venereol; 2010 May; 90(3):308-9. PubMed ID: 20526557
[No Abstract] [Full Text] [Related]
14. Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.
Garcia-Arumi J; Morral Palau M; Montolio Gil M; Blasco Garrido H; Sararols Ramsay L; Segura García A
Br J Ophthalmol; 2006 Apr; 90(4):516-8. PubMed ID: 16547342
[No Abstract] [Full Text] [Related]
15. Livedo reticularis: a side effect of interferon therapy in a pediatric patient with melanoma.
Fox M; Tahan S; Kim CC
Pediatr Dermatol; 2012; 29(3):333-5. PubMed ID: 21575046
[TBL] [Abstract][Full Text] [Related]
16. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric complications associated with interferon - alpha -2b treatment of malignant melanoma.
Enudi W; Udolu OJ
Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):227-8. PubMed ID: 19750253
[TBL] [Abstract][Full Text] [Related]
18. Focal neurological signs and symptoms induced by interferon-alpha in two patients with malignant melanoma.
Herbst RA; Gutzmer R; Jung EG; Kapp A; Weiss J
Br J Dermatol; 1997 Dec; 137(6):1022-3. PubMed ID: 9470935
[No Abstract] [Full Text] [Related]
19. Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma.
Massaguer S; Sánchez M; Castel T
Eur Radiol; 2004 Sep; 14(9):1716-7. PubMed ID: 14740162
[No Abstract] [Full Text] [Related]
20. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
Schmidgen MI; Butsch F; Schadmand-Fischer S; Steinbrink K; Grabbe S; Weidenthaler-Barth B; Loquai C
J Dtsch Dermatol Ges; 2017 Jul; 15(7):742-745. PubMed ID: 28622432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
